Impairment of small airways in COPD patients with frequent exacerbations and effects of treatment with tiotropium

International Journal of COPD

Volumn 3, Issue 1, 2008, Pages 123-126

  Incorvaia, Cristoforo ^a,d   Riario Sforza, Gian Galeazzo ^a   Pravettoni, Chiara ^a   Yacoub, Mona Rita ^b   Frati, Franco ^c  

^a ICP Hospital   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c UNIVERSITY OF PERUGIA   (Italy)

^d NONE   (Italy)

Author keywords

COPD; Exacerbations; FEF25 75; Small airways; Tiotropium

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; LONG ACTING DRUG; SHORT ACTING DRUG; TIOTROPIUM BROMIDE;

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE EXACERBATION; DRUG EFFICACY; DRUG RESPONSE; FEMALE; FORCED EXPIRATORY FLOW; FORCED EXPIRATORY VOLUME; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; POWDER INHALER; RECOMMENDED DRUG DOSE; RESIDUAL VOLUME; SMALL AIRWAY DISEASE; TREATMENT DURATION;

ACUTE DISEASE; AGED; AGED, 80 AND OVER; BRONCHODILATOR AGENTS; FEMALE; FOLLOW-UP STUDIES; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SCOPOLAMINE DERIVATIVES; TREATMENT OUTCOME; VITAL CAPACITY;

EID: 42149152127     PISSN: 11769106     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. American Thoracic Society. 1995. Standardization of spirometry: 1994 update. Am J Respir Crit Care Med, 152:1107-36.
2. Barnes PJ. 1993. Muscarinic receptor subtypes in airways. Life Sci, 52:521-27.
3. Barnes PJ. 2000. Chronic obstructive pulmonary disease. N Engl J Med, 343:269-80.
4. Barr RG, Bourbeau J, Camargo CA, et al. 2005. Inhaled tiotropium for stable chronic obstructive pulmonary disease. Cochrane Database Syst Rev, CD002876.
5. Brusasco V, Hodder R, Miravitlles M, et al. 2003. Health outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol in patients with COPD. Thorax, 58:399-404.
6. Casaburi R, Briggs DD Jr, Donohue JF, et al. 2000. The spirometric efficacy of once-daily dosing with tiotropium in stable COPD: a 13-week multicenter trial. The US Tiotropium Study Group. Chest, 118:1294-302.
7. Cazzola M, Noschese P, Salzillo A, et al. 2005. Bronchodilator response to formoterol after regular tiotropium or to tiotropium after regular formoterol in COPD patients. Respir Med, 99:524-28.
8. Dahl R, Backer V, Ollgaard B, et al. 2003. Assessment of patients performance of the HandiHaler compared with the metered dose inhaler four weeks after instructions. Respir Med, 97:1126-33.
9. Donaldson GC, Seemungal TAR, Bhowmik A, et al. 2002. Relationship between exacerbations frequency and lung function decline in chronic obstructive lung disease. Thorax, 57:847-52.
10. Garcia-Aymerich J, Monso E, Marrades RM, et al. 2001. Risk factors for hospitalization for a chronic obstructive pulmonary disease exacerbation. EFRAM study. Am J Respir Crit Care Med, 164:1002-7.
11. Hogg JC, Chu F, Utokaparch S, et al. 2004. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med, 350:2645-53.
12. Incorvaia C, Riario-Sforza GG, Pravettoni C, et al. 2007. Effects of replacing oxitropium with tiotropium on pulmonary function in patients with COPD: a randomized study. Respir Med, 101:476-80.
13. 1 decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 164:358-64.
14. Murray CJ, Lopez AD. 1997. Alternative projection of mortality by cause 1990-2020: global burden of disease study. Lancet, 349:1498-504.
15. Pauwels R, Calverley P, Buist AS, et al. 2004. COPD exacerbations: the importance of a standard definition. Respir Med, 98:99-107.
16. Phua GC, Macintyre NR. 2007. Inhaled corticosteroids in obstructive airway disease. Respir Care, 52:852-8.
17. Powrie DJ, Wilkinson TM, Donaldson GC, et al. 2007. Effect of tiotropium on sputum and serum inflammatory markers and exacerbations in COPD. Eur Respir J, 30:472-8.
18. Rabe KF, Hurd S, Anzueto A, et al. 2007. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. GOLD executive summary. Am J Respir Crit Care Med, 176:532-55.
19. Riario-Sforza GG, Incorvaia C, Paterniti F, et al. 2005. Different outcomes of pulmonary rehabilitation in patients with COPD with or without exacerbations. Monaldi Arch Chest Dis, 63:129-32.
20. Sutherland ER, Cherniak RM. 2004. Management of chronic obstructive pulmonary disease. N Engl J Med, 350:2689-97.
21. The National Collaborating Centre for Chronic Conditions. 2004. National clinical guideline on management of chronic obstructive pulmonary disease in adults in primary and secondary care. Thorax, 59(suppl 1):1-232.